Risk factor
Strong & resilient to price shocks
Profitability factor
Strong growth
About
Gr. Sarantis S.A., together with its associated companies, specializes in the manufacturing and distribution of a diverse array of consumer products, encompassing beauty items, home essentials, and health-related goods. Its business operations are structured into four principal divisions: Mass Market Cosmetics, Household Products, Other Sales categories, and Private Label Products. The company offers a comprehensive range of personal care solutions, including products for infants, body cleansing, grooming, hair care (such as colorants and styling aids), hand hygiene, oral health, intimate care, shaving, skincare, sun protection, deodorants, and perfumes. For the home, its portfolio covers dishwashing detergents, drain maintenance, food packaging materials, pest control, shoe care products, bathroom cleaners, various cleaning implements, septic tank activators, and refuse bags. Healthcare offerings include nutritional supplements, general health and self-care items, alongside specialized skin and sun care formulations. Additional cosmetic lines feature candles, makeup, beauty treatments, and home fragrances. Moreover, it supplies professional-grade cleaning tools, detergents, and various food and industrial packaging solutions. These products are made available through a wide network of sales points, including hypermarkets, supermarkets, local grocery stores, beauty retailers, and pharmacies. Gr. Sarantis S.A. maintains a robust operational presence across numerous European countries, such as Greece, Poland, Romania, Bulgaria, Serbia, the Czech Republic, Slovakia, Hungary, North Macedonia, Bosnia, Portugal, Ukraine, Russia, Cyprus, and France. Furthermore, the company actively exports its merchandise to approximately 50 nations spanning Europe, Asia, Africa, and Oceania. Established in 1930, the firm has its corporate headquarters in Athens, Greece.
Company Valuation
From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. Specifically, the stock is fairly valued on P/E, neutral on EV/EBIT
Target Price
The average target price of SAR.AT is 14 and suggests 4.83% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to d